Tag: GLP-1 API ban

11 Jan

Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
The FDA uses Import Alerts to block drugs from manufacturers with repeated quality violations. The 2025 GLP-1 crackdown targets unsafe APIs, forces compliance through a Green List system, and is reshaping global pharma supply chains.

By: Jarrett Kingsbury 13 Comments Read More